[FORM F-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHINA CORD BLOOD CORPORATION Cayman Islands Not Applicable (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) th 48 Law Debenture Corporate Services, Inc. (Name, address and telephone number of agent for service) with a copy to: Mitchell S. Nussbaum, Esq. From time to time after the] [21 September 2016 Matter No.: 822741 Doc Ref: RJH/102777384v1 Tel No.: 852 2842 9530 E-mail: Richard.Hall@conyersdill.com China Cord Blood Corporation 48 th 1 Garden Road, Central Hong Kong S.A.R. Dear Sirs, Re: China Cord Blood Corporation (the “Company”) Registration Statement Commission Securities Act Ordinary Shares Preferred Shares Equity Securities Debt Securities Rights Units Securities We have acted as special Cayman] [345 Park Avenue New York, NY 10154-1895 Direct Main Fax September 21, 2016 China Cord Blood Corporation 48 th 1 Garden Road Central, Hong Kong, S.A.R. Re: Registration Statement on Form F-3 Ladies and Gentlemen: China Cord Blood Corporation September 21, 2016 Page 2] [RATIO OF EARNINGS TO FIXED CHARGES CCBC’s ratio of earnings to fixed charges for each of the periods indicated is set forth below. We have derived the ratios of earnings to fixed charges from our historical consolidated financial statements. The ratios should be read in conjunction with our consolidated financial statements, including the notes thereto, and the other financial information] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Cord Blood Corporation: We consent to the use of our report dated July 31, 2015, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31, 2015, and the related consolidated statements of comprehensive income, changes in equity, and cash flows] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Cord Blood Corporation: We consent to the use of our reports dated July 28, 2016, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31, 2016, and the related consolidated statements of comprehensive income, changes in equity, and cash flows] [China Cord Blood Corporation Central Hong Kong S.A.R. Madams and Sirs, EX-23.5 7 a16-18402_1ex23d5.htm EX-23.5]